What Happened?
Seattle, WA-based Impel NeuroPharma Appointed Paula Kim as Vice President of Operations
About the Company
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
About the Person
Paula Kim is Vice President of Operations at Impel NeuroPharma. Previously, Paula held various senior HR leadership roles in the industry.
Info Source
News
Short Profile